PAH and major depressive disorder: Another important aspect in the pathogenesis of depression and fatigue might represent the phenylalanine–tyrosine pathway which is controlled by enzyme phenylalanine 4-hydroxylase (PAH) and represents the starting point of the biosynthetic pathway of noradrenergic, adrenergic and dopaminergic neurotransmitters.